Status:
COMPLETED
Optimizing Analgesia for Endometrial Biopsy
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Analgesia
Eligibility:
FEMALE
18-75 years
Phase:
PHASE4
Brief Summary
Comparison of the effectiveness of intrauterine lidocaine-paracervical block-dexketoprofen tromematol- lidocaine spray in endometrial biopsy analgesia
Eligibility Criteria
Inclusion
- women aged 18-75 needs endometrial biopsy
Exclusion
- women with allergies to prilocaine, lidocaine or dexketoprofen trometamol
- women with a history of severe uncontrolled cardiovascular disease, diabetes mellitus, pregnancy, vaginal, cervical, or pelvic infection, cervical cancer, or severe cervical stenosis
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
197 Patients enrolled
Trial Details
Trial ID
NCT06540599
Start Date
September 1 2022
End Date
November 1 2022
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpaşa Training and Research Hospital
Istanbul, Turkey (Türkiye)